Mankind Pharma Ltd. (NSE:MANKIND) Filings

Mankind Pharma Ltd.

Filings

FilingDateTypeFiled with
Mankind Pharma Limited has informed the Exchange regarding a press release dated October 26, 2026, titled "Press Release on Financial Results for Q2 & H1 FY27".Oct 26, 2026ResultsNSE India
Mankind Pharma Limited has informed the Exchange regarding a press release dated October 15, 2026, titled "Press Release titled Mankind Pharma to Acquire Majority Stake in Armed Cell Therapeutics, Marking Strategic Entry into Next-Generation CAR-T Therapies ".Oct 15, 2026Acquisition or disposalNSE India
Mankind Pharma Ltd. Press Release Aug 20 2026Aug 20, 2026Other filingsNSE India
Mankind Pharma Ltd. Press Release Jul 30 2026Jul 30, 2026ResultsNSE India
Press Release May 19 2026May 19, 2026ResultsNSE India
Press Release Mar 18 2026Mar 18, 2026Acquisition or disposalNSE India
Press Release Feb 03 2026Feb 3, 2026ResultsNSE India
Press Release Nov 06 2025Nov 6, 2025ResultsNSE India
Press Release Jul 31 2025Jul 31, 2025ResultsNSE India
Press Release May 21 2025May 21, 2025Other filingsNSE India
Press Release Jan 23 2025Jan 23, 2025ResultsNSE India
Press Release Nov 05 2024Nov 5, 2024ResultsNSE India
Press Release Oct 23 2024Oct 23, 2024Acquisition or disposalNSE India
Press Release Jul 31 2024Jul 31, 2024Other filingsNSE India
Press Release Jul 25 2024Jul 25, 2024Acquisition or disposalNSE India
Press Release May 15 2024May 15, 2024ResultsNSE India
Press Release Mar 11 2024Mar 11, 2024Other filingsNSE India
Press Release Jan 31 2024Jan 31, 2024ResultsNSE India
Press Release Oct 31 2023Oct 31, 2023Other filingsNSE India
Press Release Aug 02 2023Aug 2, 2023ResultsNSE India
Press Release May 30 2023May 30, 2023ResultsNSE India